Study finds metformin reduced COVID-19 death risks in women
Metformin is an established, generic medication for managing blood sugar levels in patients with type 2 diabetes.
Research & Development News
KU Leuven vaccine candidate protects against COVID-19 and yellow fever
UK medicines regulator gives approval for first UK COVID-19 vaccine
The decision by the UK regulatory authority was made with advice from the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body.
Predict cellular drug targets against COVID-19
Doctors use existing treatment earlier to save the lives of COVID-19 patients
Dr Luigi Sedda of Lancaster University analysed the results from the team at Wrightington, Wigan and Leigh Teaching Hospitals NHS Trust (WWL). Their research has now been published in the prestigious medical journal BMJ Respiratory Open.
European Commission approves contract with Moderna to ensure access to a potential vaccine
Today, the European Commission approved a sixth contract under the EU Vaccines Strategy, this time with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States, plus an option to request up to a further 80 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. New therapy for flu may help in fight against COVID-19
In an average year, more than 2 million people in the United States are hospitalized with the flu, and 30,000 to 80,000 of them die from the flu or related complications.
More Pharma News ...
Business & Industry
- Pfizer and BioNTech achieve first authorization in the world for a vaccine to combat COVID-19
- Moderna announces primary efficacy analysis in Phase 3 COVE study for its COVID-19 vaccine candidate and filing today with U.S. FDA for Emergency Use Authorization
- Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives interim authorization from Health Canada as a treatment for COVID-19
- AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
- Pfizer and BioNTech to submit Emergency Use Authorization request today to the U.S. FDA for COVID-19 vaccine
Research & Development
- Study finds metformin reduced COVID-19 death risks in women
- KU Leuven vaccine candidate protects against COVID-19 and yellow fever
- UK medicines regulator gives approval for first UK COVID-19 vaccine
- Predict cellular drug targets against COVID-19
- Doctors use existing treatment earlier to save the lives of COVID-19 patients
- European Commission approves contract with Moderna to ensure access to a potential vaccine
- New therapy for flu may help in fight against COVID-19
Conferences & Events
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
- COVID-19 vaccine innovation could dramatically speed up worldwide production
- Wearable Injectors and Connected Devices Conference 2020
Regulatory Affairs
- EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
- EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine
- FDA authorizes monoclonal antibodies for treatment of COVID-19
- FDA approves first treatment for COVID-19
- EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation